Optimal Electrolyte Seltzer

Optimal Electrolyte Seltzer

Seeking Health4.7 (382 ratings)
Format:Powder Quantity: 30 Stick Pack(s) · 30 servings
Goals
$40.00 $1.33 per serving

Product analysis

61 out of 100

Optimal Electrolyte Seltzer combines magnesium and potassium to support normal electrolyte balance. The magnesium blend proportions are undisclosed, which makes its contribution harder to compare with alternatives.

AI assessment of the formula, label and price. How scoring works

Nutrient Quality54

Potassium has a favorable identified form, and the niacin type is clear. The available information does not establish the quality of the magnesium mixture or several other ingredients.

Ingredient Transparency67

Ingredient amounts are disclosed and many forms are named. Undisclosed shares within mixtures make their exact composition harder to compare.

Value For Money48

Sodium and potassium are the more favorable reasons to consider the serving cost. Niacin and taurine offer weaker value, while magnesium value remains uncertain.

Customer Satisfaction76

Customer ratings are strongly positive. The larger review base gives a broader picture of customer satisfaction.

Product Focus69

Magnesium and potassium connect the formula to electrolyte balance and limited blood-pressure support. Taurine is present below the relevant research exposure, so the blend does not establish a reliable blood-pressure effect.

Format
Powder
Container
30 Stick Pack(s)
Per serving
$1.33
Customer rating
4.7 · 382 ratings
Report analysis

Goals

Heart Health
Impact
High effect
C Ingredient FitD+ PathwaysA EvidenceA+ Formulation Logic
Magnesium · 150 mgTaurine · 250 mg

Magnesium and potassium contribute to electrolyte balance and offer limited blood-pressure support. Potassium effects depend on starting intake and blood pressure; the serving amount does not establish a proven blood-pressure regimen. Taurine has selected-population blood-pressure evidence, but this serving provides much less than the studied exposure. These ingredients do not establish prevention of cardiovascular events.

How this product is rated for Heart Health

Ingredient fit63

Potassium, Magnesium provide the main relevant connections. Serving amounts and the breadth of the formula limit the connection to this goal.
Goal fit
Relevant ingredients sit within a broader formula, so only part of the ingredient mix connects to this goal.
Dose adequacy
The serving amounts provide partial exposure relative to the saved references, limiting how closely they resemble the compared exposures.

Pathways51

The strongest recorded connection is electrolyte balance and vascular tone. The formula has a narrow mechanism profile for this goal.
Depth
The strongest recorded connection is electrolyte balance and vascular tone; this describes a mechanism or marker rather than a proven clinical outcome.
Breadth
Meaningful recorded coverage is concentrated in electrolyte balance and vascular tone, leaving the broader goal only partly addressed.

Evidence94

Taurine leads the recognized evidence. The supporting arterial-stiffness findings have population and exposure limits.
Evidence strength
Taurine leads the recognized evidence. Its supplied limitations still apply; recognition does not establish cardiovascular-event prevention.
Studied preparation
The saved findings recognize the eligible preparations, without establishing that the finished product reproduces trial effects.

Formulation logic100

No required partner is missing and no configured conflict was found. Recognized ingredients meet the saved exposure threshold without establishing extra benefit from combining them.
Partner coverage
The recognized ingredients can contribute without an additional required partner; this does not establish synergy.
Conflicts
No configured ingredient conflict was identified in the supplied facts; this is a limited interaction check.
Effective doses
All ingredients included in this finding meet the saved minimum exposure threshold; that threshold is not proof of clinical effectiveness.
Study evidence
Magnesium Supportive 158 studies
Niacin Supportive 105 studies
Potassium Supportive 182 studies
Taurine Supportive 25 studies

Ingredients

IngredientAmount per servingScore
Calories
15 Calorie(s)
Total Carbohydrates
4 Gram(s)
Niacin (Inositol Hexanicotinate)
25 mg 54
Magnesium (Creatine MagnaPower, Dimagnesium Malate)
150 mg
Sodium (Sodium Bicarbonate)
140 mg 70
Potassium (Potassium Bicarbonate)
510 mg 91
D-Ribose
2 Gram(s)
Taurine
250 mg 57
Creatine MagnaPower (Albion Magnesium Creatine Chelate)
225 mg
Gluten Free Adults 18–50 Dairy Free
Report overview
A+ Active Ingredient Quality & BioavailabilityA- Dose, Safety & Label TransparencyB+ Value
A serving supplies 510 mg of potassium, a relatively substantial amount. The stated form is potassium bicarbonate.
How this ingredient is rated

Active Ingredient Quality & Bioavailability100

The stated potassium form is potassium bicarbonate; its presence alone does not establish how much is absorbed.
Potassium Form Quality
The stated potassium form is potassium bicarbonate; its presence alone does not establish how much is absorbed.

Dose, Safety & Label Transparency88

A serving supplies 510 mg of potassium, a relatively substantial amount. The potassium amount is listed, though the saved label evidence does not explicitly use the phrase “elemental potassium.”
Potassium Dosage Potency
A serving supplies 510 mg of potassium, a relatively substantial amount.
Elemental Yield Transparency
The potassium amount is listed, though the saved label evidence does not explicitly use the phrase “elemental potassium.”

Value80

A whole-product serving costs about $1.33.
Potassium Value Efficiency
A whole-product serving costs about $1.33.
B- Active Ingredient Quality & BioavailabilityC+ Dose, Safety & Label TransparencyB+ Value
A serving provides 140 mg sodium, a small amount for athletic replenishment. The sodium comes from sodium bicarbonate.
How this ingredient is rated

Active Ingredient Quality & Bioavailability70

Sodium is identified as coming from sodium bicarbonate. Sodium bicarbonate is recognized as a buffering form.
Sodium Source Purity & Quality
Sodium is identified as coming from sodium bicarbonate.
Bioavailability of Supporting Electrolytes
A supporting electrolyte has a form the evaluation considers readily absorbed.
Trace Mineral Complex & Buffering Forms
Sodium bicarbonate is recognized as a buffering form.

Dose, Safety & Label Transparency65

The serving has 140 mg sodium, with amounts recorded for the listed electrolytes. The available ingredient information identifies no artificial colors or sweeteners.
Sodium Dosage for Athletic Replenishment
140 mg sodium per serving is a small amount for athletic replenishment.
Ingredient Label Transparency
The listed amounts include sodium at 140 mg, potassium at 510 mg, magnesium at 150 mg per serving.
Artificial Color and Sweetener Disclosure
The available ingredient information identifies no artificial colors or sweeteners.

Value80

The whole-product serving costs about $1.33.
Price Per Serving vs. Collection Median
The whole-product serving costs about $1.33.
C- Active Ingredient Quality & BioavailabilityC+ Dose, Safety & Label TransparencyF Value
Each serving supplies 25 undefined of niacin as inositol hexanicotinate. The amount has a provisional assessment, and the whole-product serving costs about $1.33.
How this ingredient is rated

Active Ingredient Quality & Bioavailability57

Inositol hexanicotinate is the identified niacin form. Its fit for general use and source assessment are both less certain in the evaluation.
Niacin Form & Goal Alignment
Inositol hexanicotinate receives a moderate assessment for the general product context.
Precursor Source Quality
The evaluation gives inositol hexanicotinate a provisional source assessment.

Dose, Safety & Label Transparency67

The label identifies inositol hexanicotinate and 25 undefined of niacin per serving. The amount has a provisional assessment, and no no-flush claim is recorded in the saved facts.
Clarity of Chemical Form
The saved facts identify the niacin form as Inositol Hexanicotinate.
Form-Specific Dosage Efficacy
The evaluation gives the 25 undefined niacin amount a provisional assessment for this form.
Flush Risk & Safety Labeling
No no-flush claim is recorded in the saved facts; the form receives a neutral flush assessment.

Value20

A whole-product serving costs about $1.33, which the evaluation considers high for this form; the price covers the whole product.
Price Per Effective Serving
A whole-product serving costs about $1.33, which the evaluation considers high for this form; the price covers the whole product.
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Quantitative Association Between Serum/Dietary Magnesium and Cardiovascular Disease/Coronary Heart Disease Risk: A Dose-Response Meta-analysis of Prospective Cohort Studies.
    Zhao L; Hu M; Yang L; Xu H; Song W; Qian Y; Zhao M · Journal of cardiovascular pharmacology · 2020
    Meta-analysis544,581 participants18 studies pooledHeart Health forMagnesium
  2. Effects of magnesium supplementation on improving hyperglycemia, hypercholesterolemia, and hypertension in type 2 diabetes: A pooled analysis of 24 randomized controlled trials.
    Xu L; Li X; Wang X; Xu M · Frontiers in nutrition · 2023
    Meta-analysis1,325 participants24 studies pooledHeart Health forMagnesium
  3. The effect of lowering blood pressure by magnesium supplementation in diabetic hypertensive adults with low serum magnesium levels: a randomized, double-blind, placebo-controlled clinical trial.
    Guerrero-Romero F; Rodríguez-Morán M · Journal of human hypertension · 2009
    Randomized trial82 participantsHeart Health forMagnesium
  4. Positive effects of magnesium supplementation in metabolic syndrome.
    Kisters S; Kisters K; Werner T; Vormann J; Tokmak F; Westhoff T; Gröber U; Predel HG; Reuter H · International journal of clinical pharmacology and therapeutics · 2024
    Randomized trial54 participantsHeart Health forMagnesium
  5. Comparative Efficacy of Nutraceuticals on Endothelial Function: A Systematic Review and Network Meta-Analysis.
    Norouzzadeh M; Rashedi MH; Mahdavi-Mazdeh G; Kosari A; Shahinfar H · Current atherosclerosis reports · 2026
    Meta-analysisHeart Health forMagnesium
  6. Differential effect of two nicotinic acid preparations on low-density lipoprotein subclass distribution in patients classified as low-density lipoprotein pattern A, B, or I.
    Superko HR; McGovern ME; Raul E; Garrett B · The American journal of cardiology · 2004
    Randomized trial180 participantsHeart Health forNiacin
  7. The ARBITER 6-HALTS Trial (Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol 6-HDL and LDL Treatment Strategies in Atherosclerosis): final results and the impact of medication adherence, dose, and treatment duration.
    Villines TC; Stanek EJ; Devine PJ; Turco M; Miller M; Weissman NJ; Griffen L; Taylor AJ · Journal of the American College of Cardiology · 2010
    Randomized trial315 participantsHeart Health forNiacin
  8. The effects of extended-release niacin on carotid intimal media thickness, endothelial function and inflammatory markers in patients with the metabolic syndrome.
    Thoenes M; Oguchi A; Nagamia S; Vaccari CS; Hammoud R; Umpierrez GE; Khan BV · International journal of clinical practice · 2008
    Randomized trial50 participantsHeart Health forNiacin
  9. Effect of niacin therapy on cardiovascular outcomes in patients with coronary artery disease.
    Duggal JK; Singh M; Attri N; Singh PP; Ahmed N; Pahwa S; Molnar J; Singh S; Khosla S; Arora R · Journal of cardiovascular pharmacology and therapeutics · 2010
    Meta-analysis5,137 participants7 studies pooledHeart Health forNiacin
  10. Effect of niacin on endothelial function: a systematic review and meta-analysis of randomized controlled trials.
    Sahebkar A · Vascular medicine (London, England) · 2014
    Meta-analysis441 participants7 studies pooledHeart Health forNiacin
  11. Potassium intake, stroke, and cardiovascular disease a meta-analysis of prospective studies.
    D'Elia L; Barba G; Cappuccio FP; Strazzullo P · Journal of the American College of Cardiology · 2011
    Meta-analysis247,510 participants11 studies pooledHeart Health forPotassium
  12. Oral potassium supplementation for management of essential hypertension: A meta-analysis of randomized controlled trials.
    Poorolajal J; Zeraati F; Soltanian AR; Sheikh V; Hooshmand E; Maleki A · PloS one · 2017
    Meta-analysis1,213 participants23 studies pooledHeart Health forPotassium
  13. Joint association of urinary sodium and potassium excretion with cardiovascular events and mortality: prospective cohort study.
    O'Donnell M; Mente A; Rangarajan S; McQueen MJ; O'Leary N; Yin L; Liu X; Swaminathan S; Khatib R; Rosengren A; Ferguson J; Smyth A; Lopez-Jaramillo P; Diaz R; Avezum A; Lanas F; Ismail N; Yusoff K; Dans A; Iqbal R; Szuba A; Mohammadifard N; Oguz A; Yusufali AH; Alhabib KF; Kruger IM; Yusuf R; Chifamba J; Yeates K; Dagenais G; Wielgosz A; Lear SA; Teo K; Yusuf S; PURE Investigators · BMJ (Clinical research ed.) · 2019
    Cohort study103,570 participantsHeart Health forPotassium
  14. Effect of Potassium Supplementation on Endothelial Function: A Systematic Review and Meta-Analysis of Intervention Studies.
    D'Elia L; Cappuccio FP; Masulli M; La Fata E; Rendina D; Galletti F · Nutrients · 2023
    Meta-analysis332 participants5 studies pooledHeart Health forPotassium
  15. Effects of potassium supplementation on office, home, and 24-h blood pressure in patients with essential hypertension.
    Kawano Y; Minami J; Takishita S; Omae T · American journal of hypertension · 1999
    Randomized trial55 participantsHeart Health forPotassium
  16. Taurine ameliorates blood pressure and vascular function in patients with type 2 diabetes: Randomized, double-blind, placebo-controlled trial.
    Li Y; Wang Q; Liu Y; Li Q; Xia W; Lin S; Yang Q; Scholze A; Zhao Z; He H; Zhang H; Yan Z; Tepel M; Mu H; Zhu Z; Liu D · iScience · 2025
    Randomized trial165 participantsHeart Health forTaurine
  17. Seafood diets: hypolipidemic and antiatherogenic effects of taurine and n-3 fatty acids.
    Elvevoll EO; Eilertsen KE; Brox J; Dragnes BT; Falkenberg P; Olsen JO; Kirkhus B; Lamglait A; Østerud B · Atherosclerosis · 2009
    Randomized trial80 participantsHeart Health forTaurine
  18. Taurine Supplementation Lowers Blood Pressure and Improves Vascular Function in Prehypertension: Randomized, Double-Blind, Placebo-Controlled Study.
    Sun Q; Wang B; Li Y; Sun F; Li P; Xia W; Zhou X; Li Q; Wang X; Chen J; Zeng X; Zhao Z; He H; Liu D; Zhu Z · Hypertension (Dallas, Tex. : 1979) · 2016
    Randomized trial120 participantsHeart Health forTaurine
  19. The effects of taurine supplementation on obesity, blood pressure and lipid profile: A meta-analysis of randomized controlled trials.
    Guan L; Miao P · European journal of pharmacology · 2021
    Meta-analysis12 studies pooledHeart Health forTaurine
  20. The Effects of Oral Taurine on Resting Blood Pressure in Humans: a Meta-Analysis.
    Waldron M; Patterson SD; Tallent J; Jeffries O · Current hypertension reports · 2019
    Meta-analysis103 participants7 studies pooledHeart Health forTaurine